Monocyte/macrophage proteomics: Recent findings and biomedical applications

Expert Review of Proteomics

Volumn 9, Issue 2, 2012, Pages 201-215

  Castagna, Annalisa ^a   Polati, Rita ^b   Bossi, Alessandra Maria ^b   Girelli, Domenico ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

Author keywords

atherosclerosis; human macrophages; iron metabolism; monocytes; proteomics

Indexed keywords

ALBUMIN PRECURSOR; ALPHA1 ENOLASE; ARYLDIALKYLPHOSPHATASE 1; ATORVASTATIN; CATHEPSIN D; CD16 ANTIGEN; CHAIN A ENDONUCLEASE; CHAIN A NUCLEASE DNASE; CHAIN A RIBONUCLEASE INHIBITOR ANGIOGENIN COMPLEX; CHAIN A TRIOSEPHOSPHATE ISOMERASE; FICOLIN; GLUTATHIONE TRANSFERASE; HEAT SHOCK COGNATE 71; HEAT SHOCK PROTEIN 60; HEAT SHOCK PROTEIN 70; LIPOCORTIN 1; LIPOCORTIN 2; M2 ISOZYME; MATURE CATHEPSIN D; MY032 PROTEIN; NUCLEASE; ONCOGENE DJ1 PROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; PHOSPHOGLYCERATE KINASE 1; PROHIBITIN; PYRUVATE KINASE; RIBONUCLEASE; SOMATOMEDIN B RECEPTOR; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ACUTE CORONARY SYNDROME; ATHEROSCLEROSIS; BIOCHEMISTRY; CANCER RESEARCH; CELL STRAIN U937; CORONARY ARTERY DISEASE; GEL ELECTROPHORESIS; HUMAN; IN VITRO STUDY; INFLAMMATION; IRON METABOLISM DISORDER; MACROPHAGE; MASS SPECTROMETRY; MONOCYTE; MONOCYTE MACROPHAGE PRECURSOR CELL; NONHUMAN; PATHOPHYSIOLOGY; PROTEOMICS; REVIEW; T LYMPHOCYTE ACTIVATION; TH1 CELL;

ANIMALS; ARTERIOSCLEROSIS; BIOLOGICAL MARKERS; HUMANS; INFLAMMATION; IRON; MACROPHAGES; MONOCYTES; PROTEOME; PROTEOMICS; TERMINOLOGY AS TOPIC;

EID: 84859396928     PISSN: 14789450     EISSN: 17448387     Source Type: Journal    
DOI: 10.1586/epr.12.11     Document Type: Review

References (109)

1. Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5(12), 953-964 (2005).
2. Sunderkötter C, Nikolic T, Dillon MJ et al. Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response. J. Immunol. 172(7), 4410-4417 (2004).
3. Passlick B, Flieger D, Ziegler-Heitbrock HW. Identification and characterization of a novel monocyte subpopulation in human peripheral blood. Blood 74(7), 2527-2534 (1989).
4. Ziegler-Heitbrock L, Ancuta P, Crowe S et al. Nomenclature of monocytes and dendritic cells in blood. Blood 116(16), e74-e80 (2010). Update on monocyte nomenclature.
5. Gordon S. The macrophage: past, present and future. Eur. J. Immunol. 37(Suppl. 1), S9-S17 (2007).
6. Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M, Ley K. Development of monocytes, macrophages, and dendritic cells. Science 27(5966), 656-661 (2010).
7. Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8(12), 958-969 (2008).
8. Kono H, Rock KL. How dying cells alert the immune system to danger. Nat. Rev. Immunol. 8(4), 279-289 (2008).
9. Gordon S. Alternative activation of macrophages. Nat. Rev. Immunol. 3(1), 23-35 (2003).
10. Mantovani A, Sica A, Locati M. Macrophage polarization comes of age. Immunity 23(4), 344-346 (2005).
11. Stout RD, Jiang C, Matta B, Tietzel I, Watkins SK, Suttles J. Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences. J. Immunol. 175(1), 342-349 (2005).
12. Zak DE, Aderem A. Systems biology of innate immunity. Immunol. Rev. 227(1), 264-282 (2009).
13. Wu HM, Jin M, Marsh CB. Toward functional proteomics of alveolar macrophages. Am. J. Physiol. Lung Cell Mol. Physiol. 288(4), L585-L595 (2005).
14. Haudek VJ, Slany A, Gundacker NC, Wimmer H, Drach J, Gerner C. Proteome maps of the main human peripheral blood constituents. J. Proteome Res. 8(8), 3834-3843 (2009).
15. Rabilloud T. Variations on a theme: changes to electrophoretic separations that can make a difference. J. Proteomics 73(8), 1562-1572 (2010).
16. Tran JC, Zamdborg L, Ahlf DR et al. Mapping intact protein isoforms in discovery mode using top-down proteomics. Nature 480, 254-258 (2011).
17. Gygi SP, Rist B, Gerber SA, Turecek F, Gelb MH, Aebersold R. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat. Biotechnol. 17(10), 994-999 (1999).
18. Ross PL, Huang YN, Marchese JN et al. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol. Cell Proteomics 3(12), 1154-1169 (2004).
19. Ong SE, Blagoev B, Kratchmarova I et al. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell Proteomics 1(5), 376-386 (2002).
20. De Bock M, de Seny D, Meuwis MA et al. Challenges for biomarker discovery in body fluids using SELDI-TOF-MS. J. Biomed. Biotechnol. 2010, 906082 (2010).
21. Walsh GM, Rogalski JC, Klockenbusch C, Kast J. Mass spectrometry-based proteomics in biomedical research: emerging technologies and future strategies. Expert Rev. Mol. Med. 12, e30 (2010). Detailed review of mass spectometry-based approaches for clinical proteomics, highlighting both research strategies and technical aspects.
22. Waldo SW, Li Y, Buono C et al. Heterogeneity of human macrophages in culture and in atherosclerotic plaques. Am. J. Pathol. 172(4), 1112-1126 (2008).
23. Chorváth B, Sedlák J, Hunáková L et al. Human monoblastoid cell line U-937 cultured in protein-free medium: immunophenotype, cytochemical and biochemical markers. Neoplasma 38(5), 483-492 (1991).
24. Singhto N, Sintiprungrat K, Sinchaikul S, Chen ST, Thongboonkerd V. Proteome changes in human monocytes upon interaction with calcium oxalate monohydrate crystals. J. Proteome Res. 9(8), 3980-3988 (2010). References [24-27] are papers regarding the use of the U937 cell line.
25. Lu MC, Lai NS, Yu HC, Huang HB, Hsieh SC, Yu CL. Anti-citrullinated protein antibodies bind surface-expressed citrullinated Grp78 on monocyte/macrophages and stimulate tumor necrosis factor aproduction. Arthritis Rheum. 62(5), 1213-1223 (2010).
26. Severino V, Chambery A, Vitiello M et al. Proteomic analysis of human U937 cell line activation mediated by Haemophilus influenzae type b P2 porin and its surface-exposed loop 7. J. Proteome Res. 9(2), 1050-1062 (2010).
27. Sintiprungrat K, Singhto N, Sinchaikul S, Chen ST, Thongboonkerd V. Alterations in cellular proteome and secretome upon differentiation from monocyte to macrophage by treatment with phorbol myristate acetate: insights into biological processes. J. Proteomics 73(3), 602-618 (2010). Complete study on U937 cells after phorbol myristate acetate treatment.
28. Tsuchiya S, Yamabe M, Yamaguchi Y, Kobayashi Y, Konno T, Tada K. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int. J. Cancer 26(2), 171-176 (1980).
29. Ziegler-Heitbrock HW, Thiel E, Futterer A et al. Establishment of a human cell line (Mono Mac 6) with characteristics of mature monocytes. Int. J. Cancer 41(3), 456-461 (1988).
30. Chauhan V, Qutob SS, Lui S et al. Analysis of gene expression in two human-derived cell lines exposed in vitro to a 1.9 GHz pulse-modulated radiofrequency field. Proteomics 7(21), 3896-3905 (2007).
31. Dekker LJ, van Kampen JJ, Reedijk ML et al. A mass spectrometry based imaging method developed for the intracellular detection of HIV protease inhibitors. Rapid Commun. Mass Spectrom. 23(8), 1183-1188 (2009).
32. Okuzaki D, Kimura S, Yabuta N, Ohmine T, Nojima H. LeukoCatch, a quick and efficient tool for the preparation of leukocyte extracts from blood. BMC Clin. Pathol. 11, 9 (2011).
33. Matsumura T, Oyama M, Kozuka-Hata H et al. Identification of BCAP-(L) as a negative regulator of the TLR signaling-induced production of IL-6 and IL-10 in macrophages by tyrosine phosphoproteomics. Biochem. Biophys. Res. Commun. 400(2), 265-270 (2010). References [33-39] are studies on macrophages in animal models using up-to-date proteomics technologies. This article describes application of the SILAC method to the study of phosphoproteomics in murine macrophages.
34. Zhu Z, Xue LM, Han T et al. Antiosteoporotic effects and proteomic characterization of the target and mechanism of an Er-Xian decoction on osteoblastic UMR-106 and osteoclasts induced from RAW264.7. Molecules 15(7), 4695-4710 (2010).
35. Swearingen KE, Loomis WP, Zheng M, Cookson BT, Dovichi NJ. Proteomic profiling of lipopolysaccharide-activated macrophages by isotope coded affinity tagging. J. Proteome Res. 9(5), 2412-2421 (2010).
36. Tello D, Tarín C, Ahicart P, Bretón-Romero R, Lamas S, Martínez-Ruiz A. A 'fluorescence switch' technique increases the sensitivity of proteomic detection and identification of S-nitrosylated proteins. Proteomics 9(23), 5359-5370 (2009).
37. Martínez-Solano L, Reales-Calderón JA, Nombela C, Molero G, Gil C. Proteomics of RAW 264.7 macrophages upon interaction with heat-inactivated Candida albicans cells unravel an anti-inflammatory response. Proteomics 9(11), 2995-3010 (2009).
38. Patel PC, Fisher KH, Yang EC, Deane CM, Harrison RE. Proteomic analysis of microtubule-associated proteins during macrophage activation. Mol. Cell Proteomics 8(11), 2500-2514 (2009). Multidimensional protein identification technology strategy for fine proteome analysis of microtubule-associated proteins during macrophage activation.
39. Shui W, Gilmore SA, Sheu L, Liu J, Keasling JD, Bertozzi CR. Quantitative proteomic profiling of host-pathogen interactions: the macrophage response to Mycobacterium tuberculosis lipids. J. Proteome Res. 8(1), 282-289 (2009). State-of-the-art quantitative approaches (isobaric tags for relative and absolute quantification and SILAC) applied to the proteome analysis of host-pathogen interactions using mouse macrophages.
40. Xiong M, Elson G, Legarda D, Leibovich SJ. Production of vascular endothelial growth factor by murine macrophages: regulation by hypoxia, lactate, and the inducible nitric oxide synthase pathway. Am. J. Pathol. 153(2), 587-598 (1998).
41. Jones JA, Chang DT, Meyerson H et al. Proteomic analysis and quantification of cytokines and chemokines from biomaterial surface-adherent macrophages and foreign body giant cells. J. Biomed. Mater. Res. A. 83(3), 585-596 (2007). Along with references [42-47,49,55,72,74], this article is about proteomic analysis of human monocyte-derived macrophages (MDMs).
42. McNally AK, Anderson JM. Complement C3 participation in monocyte adhesion to different surfaces. Proc. Natl Acad. Sci. USA 91(21), 10119-10123 (1994).
43. Pinet F, Dupont A, Bencherif N, Guihot AL, Quatannens B, Amouyel P. Morphology, homogeneity and functionality of human monocytes-derived macrophages. Cell Mol. Biol. 49(6), 899-905 (2003).
44. Polati R, Castagna A, Bossi A et al. High resolution preparation of monocyte-derived macrophages (MDM) protein fractions for clinical proteomics. Proteome Sci. 7, 4 (2009). Sample fractionation protocol for proteomic studies regarding MDMs.
45. Dinnes DL, Marçal H, Mahler SM, Santerre JP, Labow RS. Material surfaces affect the protein expression patterns of human macrophages: a proteomics approach. J. Biomed. Mater. Res. A. 80(4), 895-908 (2007).
46. Dupont A, Tokarski C, Dekeyzer O et al. Two-dimensional maps and databases of the human macrophage proteome and secretome. Proteomics 4(6), 1761-1778 (2004). First proteome 'atlas' of human MDMs.
47. Slomianny MC, Dupont A, Bouanou F et al. Profiling of membrane proteins from human macrophages: comparison of two approaches. Proteomics 6(8), 2365-2375 (2006).
48. Righetti PG, Boschetti E, Kravchuk AV, Fasoli E. The proteome buccaneers: how to unearth your treasure chest via combinatorial peptide ligand libraries. Expert Rev. Proteomics 7(3), 373-385 (2010).
49. Rakkola R, Matikainen S, Nyman TA. Proteome analysis of human macrophages reveals the upregulation of manganese-containing superoxide dismutase after Toll-like receptor activation. Proteomics 7(3), 378-384 (2007).
50. Petrak J, Ivanek R, Toman O et al. Déjà vu in proteomics. A hit parade of repeatedly identified differentially expressed proteins. Proteomics 8(9), 1744-1749 (2008).
51. Kislinger T, Gramolini AO, MacLennan DH, Emili A. Multidimensional protein identification technology (MudPIT): technical overview of a profiling method optimized for the comprehensive proteomic investigation of normal and diseased heart tissue. J. Am. Soc. Mass Spectrom. 16(8), 1207-1220 (2005).
52. Yates JR, Ruse CI, Nakorchevsky A. Proteomics by mass spectrometry: approaches, advances, and applications. Annu. Rev. Biomed. Eng. 11, 49-79 (2009).
53. Panchaud A, Affolter M, Moreillon P, Kussmann M. Experimental and computational approaches to quantitative proteomics: status quo and outlook. J. Proteomics 71(1), 19-33 (2008).
54. Kumar C, Mann M. Bioinformatics analysis of mass spectrometry-based proteomics data sets. FEBS Lett. 583(11), 1703-1712 (2009).
55. Brown J, Wallet MA, Krastins B, Sarracino D, Goodenow MM. Proteome bioprofiles distinguish between M1 priming and activation states in human macrophages. J. Leukocyte Biol. 87(4), 655-662 (2010).
56. Falk E. Pathogenesis of atherosclerosis. J. Am. Coll. Cardiol. 47(Suppl. 8), C7-C12 (2006).
57. Antohe F. Endothelial cells and macrophages, partners in atherosclerotic plaque progression. Arch. Physiol. Biochem. 112(4- 5), 245-253 (2006).
58. Moore KJ, Tabas I. Macrophages in the pathogenesis of atherosclerosis. Cell 145(3), 341-355 (2011).
59. Libby P. Inflammation and cardiovascular disease mechanisms. Am. J. Clin. Nutr. 83(2), 456S-460S (2006).
60. Nahrendorf M, Pittet MJ, Swirski FK. Monocytes: protagonists of infarct inflammation and repair after myocardial infarction. Circulation 121(22), 2437-2445 (2010).
61. Mantovani A, Garlanda C, Locati M. Macrophage diversity and polarization in atherosclerosis: a question of balance. Arterioscler. Thromb. Vasc. Biol. 29(10), 1419-1423 (2009).
62. Johnson JL, Newby AC. Macrophage heterogeneity in atherosclerotic plaques. Curr. Opin. Lipidol. 20(5), 370-378 (2009).
63. de la Cuesta F, Alvarez-Llamas G, Gil-Dones F et al. Tissue proteomics in atherosclerosis: elucidating the molecular mechanisms of cardiovascular diseases. Expert Rev. Proteomics 6(4), 395-409 (2009).
64. Martinet W, Knaapen MW, De Meyer GR, Herman AG, Kockx MM. Overexpression of the anti-apoptotic caspase-2 short isoform in macrophage-derived foam cells of human atherosclerotic plaques. Am. J. Pathol. 162(3), 731-736 (2003).
65. Trogan E, Choudhury RP, Dansky HM, Rong JX, Breslow JL, Fisher EA. Laser capture microdissection analysis of gene expression in macrophages from atherosclerotic lesions of apolipoprotein E-deficient mice. Proc. Natl Acad. Sci. USA 99(4), 2234-2239 (2002).
66. Vivanco F, Padial LR, Darde VM et al. Proteomic biomarkers of atherosclerosis. Biomark. Insights 3, 101-113 (2008).
67. Olson FJ, Sihlbom C, Davidsson P, Hulthe J, Fagerberg B, Bergström G. Consistent differences in protein distribution along the longitudinal axis in symptomatic carotid atherosclerotic plaques. Biochem. Biophys. Res. Commun. 401(4), 574-580 (2010).
68. Bagnato C, Thumar J, Mayya V et al. Proteomics analysis of human coronary atherosclerotic plaque: a feasibility study of direct tissue proteomics by liquid chromatography and tandem mass spectrometry. Mol. Cell Proteomics 6(6), 1088-1102 (2007).
69. de la Cuesta F, Alvarez-Llamas G, Maroto AS et al. A proteomic focus on the molecular mechanisms occurring at the atherosclerotic coronary intima. Mol. Cell Proteomics 10(4), M110.003517 (2011). First application of laser-capture microdissection in human atherosclerotic coronaries for proteomics, in association with 2D-DIGE and MS/MS.
70. Barderas MG, Tuñón J, Dardé VM et al. Circulating human monocytes in the acute coronary syndrome express a characteristic proteomic profile. J. Proteome Res. 6(2), 876-886 (2007).
71. Barderas MG, Tuñón J, Dardé VM et al. Atorvastatin modifies the protein profile of circulating human monocytes after an acute coronary syndrome. Proteomics 9(7), 1982-1993 (2009).
72. Dupont A, Chwastyniak M, Beseme O et al. Application of saturation dye 2D-DIGE proteomics to characterize proteins modulated by oxidized low density lipoprotein treatment of human macrophages. J. Proteome Res. 7(8), 3572-3582 (2008).
73. Kang JH, Kim HT, Choi MS et al. Proteome analysis of human monocytic THP-1 cells primed with oxidized low-density lipoproteins. Proteomics 6(4), 1261-1273 (2006). Along with references [75-77], this paper focuses on proteomic studies on THP-1 cells.
74. Burillo E, Recalde D, Jarauta E et al. Proteomic study of macrophages exposed to oxLDL identifies a CAPG polymorphism associated with carotid atherosclerosis. Atherosclerosis 207(1), 32-37 (2009).
75. Yang PY, Rui YC, Yang PY, Yu YL. Proteomic analysis of foam cells. Methods Mol. Biol. 357, 297-305 (2007).
76. Kang JH, Ryu HS, Kim HT et al. Proteomic analysis of human macrophages exposed to hypochlorite-oxidized low-density lipoprotein. Biochim. Biophys. Acta 1794(3), 446-458 (2009).
77. Eisenhardt SU, Habersberger J, Oliva K et al. A proteomic analysis of C-reactive protein stimulated THP-1 monocytes. Proteome Sci. 9(1), 1 (2011).
78. De Domenico I, McVey Ward D, Kaplan J. Regulation of iron acquisition and storage: consequences for iron-linked disorders. Nat. Rev. Mol. Cell Biol. 9(1), 72-81 (2008).
79. Ganz T, Nemeth E. Iron sequestration and anemia of inflammation. Semin. Hematol. 46(4), 387-393 (2009).
80. Theurl I, Fritsche G, Ludwiczek S, Garimorth K, Bellmann-Weiler R, Weiss G. The macrophage: a cellular factory at the interphase between iron and immunity for the control of infections. Biometals 18(4), 359-367 (2005).
81. Ganz T. Iron in innate immunity: starve the invaders. Curr. Opin. Immunol. 21(1), 63-67(2009).
82. Chisolm GM, Steinberg D. The oxidative modification hypothesis of atherogenesis: an overview. Free Radic. Biol. Med. 28(12), 1815-1826 (2000).
83. Yuan XM. Apoptotic macrophage-derived foam cells of human atheromas are rich in iron and ferritin, suggesting iron-catalysed reactions to be involved in apoptosis. Free Radic. Res. 30(3), 221-231 (1999).
84. Li W, Ostblom M, Xu LH et al. Cytocidal effects of atheromatous plaque components: the death zone revisited. FASEB J. 20(13), 2281-2290 (2006).
85. Geng YJ, Libby P. Progression of atheroma: a struggle between death and procreation. Arterioscler. Thromb. Vasc. Biol. 22(9), 1370-1380 (2002).
86. Recalcati S, Locati M, Marini A et al. Differential regulation of iron homeostasis during human macrophage polarized activation. Eur. J. Immunol. 40(3), 824-835 (2010).
87. Cairo G, Recalcati S, Mantovani A, Locati M. Iron trafficking and metabolism in macrophages: contribution to the polarized phenotype. Trends Immunol. 32(6), 241-247 (2011).
88. Hentze MW, Muckenthaler MU, Galy B, Camaschella C. Two to tango: regulation of mammalian iron metabolism. Cell 142(1), 24-38 (2010).
89. Weiss G. Iron and immunity: a double-edged sword. Eur. J. Clin. Invest. 32(Suppl. 1), 70-78 (2002).
90. Nemeth E, Tuttle MS, Powelson J. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306(5704), 2090-2093 (2004).
91. Theurl I, Theurl M, Seifert M et al. Autocrine formation of hepcidin induces iron retention in human monocytes. Blood 111(4), 2392-2399 (2008).
92. Jacolot S, Férec C, Mura C. Iron responses in hepatic, intestinal and macrophage/monocyte cell lines under different culture conditions. Blood Cells Mol. Dis. 41(1), 100-108 (2008).
93. Valenti L, Dongiovanni P, Motta BM et al. Serum hepcidin and macrophage iron correlate with MCP-1 release and vascular damage in patients with metabolic syndrome alterations. Arterioscler. Thromb. Vasc. Biol. 31(3), 683-690 (2011).
94. Kraml PJ, Klein RL, Huang Y, Nareika A, Lopes-Virella MF. Iron loading increases cholesterol accumulation and macrophage scavenger receptor I expression in THP-1 mononuclear phagocytes. Metabolism 54(4), 453-459 (2005).
95. Schunkert H, König IR, Kathiresan S et al. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat. Genet. 43(4), 333-338 (2011).
96. Zhao C, Zhang H, Wong WC et al. Identification of novel functional differences in monocyte subsets using proteomic and transcriptomic methods. J. Proteome Res. 8(8), 4028-4038 (2009).
97. Yu HR, Kuo HC, Huang HC et al. Identification of immunodeficient molecules in neonatal mononuclear cells by proteomic differential displays. Proteomics 11(17), 3491-3500 (2011).
98. Deng FY, Lei SF, Zhang Y et al. Peripheral blood monocyte-expressed ANXA2 gene is involved in pathogenesis of osteoporosis in humans. Mol. Cell. Proteomics 10(11), M111.011700 (2011).
99. Deng FY, Liu YZ, Li LM et al. Proteomic analysis of circulating monocytes in Chinese premenopausal females with extremely discordant bone mineral density. Proteomics 8(20), 4259-4272 (2008).
100. Jin M, Diaz PT, Bourgeois T et al. Two-dimensional gel proteome reference map of blood monocytes. Proteome Sci. 4, 16 (2006).
101. Ye X, Johann DJ Jr, Hakami RM et al. Optimization of protein solubilization for the analysis of the CD14 human monocyte membrane proteome using LC-MS/MS. J. Proteomics 73(1), 112-122 (2009).
102. Minafra L, Di Cara G, Albanese NN, Cancemi P. Proteomic differentiation pattern in the U937 cell line. Leukocyte Res. 35(2), 226-236 (2011).
103. Xiong L, Darwanto A, Sharma S et al. Mass spectrometric studies on epigenetic interaction networks in cell differentiation. J. Biol. Chem. 286(15), 13657-13668 (2011).
104. Droin N, Jacquel A, Hendra JB et al. α-defensins secreted by dysplastic granulocytes inhibit the differentiation of monocytes in chronic myelomonocytic leukemia. Blood 115(1), 78-88 (2010).
105. Parent N, Winstall E, Beauchemin M et al. Proteomic analysis of enriched lysosomes at early phase of camptothecin-induced apoptosis in human U-937 cells. J. Proteomics 72(6), 960-973 (2009).
106. Zhang L, Zhu H, Lun Y et al. Proteomic analysis of macrophages: a potential way to identify novel proteins associated with activation of macrophages for tumour cell killing. Cell. Mol. Immunol. 4(5), 359-367 (2007).
107. Seikh AA, Vimalachandran D, Thompson CC et al. The expression of S100A8 in pancreatic cancer associated monocytes is associated with the Smad4 status of pancreatic cancer cells. Proteomics 7(11), 1929-1940 (2007).
108. Macrophages.com: the macrophage community website.www.macrophages.com
109. U937 - cytokines and cells online pathfinder encyclopaedia.www. copewithcytokines.de/cope.cgi?key=U937